Literature DB >> 18083347

Organic and inorganic calcium antagonists inhibit veratridine-induced epileptiform activity in CA3 neurons of the guinea pig.

Mark Christian Link1, Martin Wiemann, Dieter Bingmann.   

Abstract

Veratridine is believed to cause epileptiform discharges via its effects on sodium channels. We addressed the question whether calcium currents, known to contribute to the generation of paroxysmal depolarization shifts (PDS) in most models of epilepsies, also contribute to veratridine-induced epileptiform activity. Therefore, we recorded from CA3 neurons (n=50) of veratridine-treated hippocampal slices and analyzed the effects of two calcium antagonists. Veratridine (0.5-1.0 microM) elicited spontaneous epileptiform bursts, paroxysmal depolarization shifts (PDS) lasting 100-300 ms, and depolarizations (LD) lasting up to several minutes. Most often PDS directly preceded LD which resulted in typical composite depolarizations termed veratridine-induced complexes (VC). VC persisted even in the presence of CNQX and APV (25 micromol/l, both), or in nominally calcium-free saline, revealing the non-synaptic nature of these potentials. Cobalt (1-2mM) abolished VC within minutes, but allowed LD type-like potentials to be elicited by depolarizing current pulses. Verapamil (50 microM) also diminished or abolished amplitudes of VC. All inhibitory effects of cobalt and verapamil were at least partly reversible. Due to the effects of both calcium antagonists we conclude that veratridine-induced epileptiform activity depends not only on sodium, but also on calcium currents.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18083347     DOI: 10.1016/j.eplepsyres.2007.11.002

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  3 in total

1.  Drug resistance in cortical and hippocampal slices from resected tissue of epilepsy patients: no significant impact of p-glycoprotein and multidrug resistance-associated proteins.

Authors:  Nora Sandow; Simon Kim; Claudia Raue; Dennis Päsler; Zin-Juan Klaft; Leandro Leite Antonio; Jan Oliver Hollnagel; Richard Kovacs; Oliver Kann; Peter Horn; Peter Vajkoczy; Martin Holtkamp; Heinz-Joachim Meencke; Esper A Cavalheiro; Fritz Pragst; Siegrun Gabriel; Thomas-Nicolas Lehmann; Uwe Heinemann
Journal:  Front Neurol       Date:  2015-02-18       Impact factor: 4.003

2.  Practical Radiosynthesis and Preclinical Neuroimaging of [11C]isradipine, a Calcium Channel Antagonist.

Authors:  Benjamin H Rotstein; Steven H Liang; Vasily V Belov; Eli Livni; Dylan B Levine; Ali A Bonab; Mikhail I Papisov; Roy H Perlis; Neil Vasdev
Journal:  Molecules       Date:  2015-05-26       Impact factor: 4.411

3.  Dl-3n-butylphthalide reduces epileptiform activity through GluA2-lacking calcium-permeable AMPARs in epilepsy models.

Authors:  Qin Yang; Yi-Da Hu; Xue-Feng Wang; Fang-Shuo Zheng
Journal:  Oncotarget       Date:  2017-10-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.